Annual EBIT
-$18.84 M
-$3.57 M-23.39%
31 December 2023
Summary:
CNS Pharmaceuticals annual earnings before interest & taxes is currently -$18.84 million, with the most recent change of -$3.57 million (-23.39%) on 31 December 2023. During the last 3 years, it has fallen by -$9.38 million (-99.24%). CNSP annual EBIT is now -391.45% below its all-time high of -$3.83 million.CNSP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$5.60 M
-$3.08 M-121.81%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly earnings before interest & taxes is currently -$5.60 million, with the most recent change of -$3.08 million (-121.81%) on 30 September 2024. Over the past year, it has dropped by -$1.08 million (-23.95%). CNSP quarterly EBIT is now -3198.23% below its all-time high of -$169.90 thousand, reached on 30 September 2018.CNSP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$17.04 M
-$1.08 M-6.78%
30 September 2024
Summary:
CNS Pharmaceuticals TTM earnings before interest & taxes is currently -$17.04 million, with the most recent change of -$1.08 million (-6.78%) on 30 September 2024. Over the past year, it has increased by +$1.56 million (+8.38%). CNSP TTM EBIT is now -6686.34% below its all-time high of -$251.10 thousand, reached on 30 June 2018.CNSP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP EBIT Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -23.4% | -23.9% | +8.4% |
3 y3 years | -99.2% | -47.0% | -19.7% |
5 y5 years | -156.5% | -701.6% | -115.0% |
CNSP EBIT High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -99.2% | at low | -121.8% | at low | -27.3% | +9.5% |
5 y | 5 years | -391.4% | at low | -701.6% | at low | -344.6% | +9.5% |
alltime | all time | -391.4% | at low | -3198.2% | +15.3% | -6686.3% | +9.5% |
CNS Pharmaceuticals EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$5.60 M(+121.8%) | -$17.04 M(+6.8%) |
June 2024 | - | -$2.53 M(-28.6%) | -$15.96 M(-8.5%) |
Mar 2024 | - | -$3.54 M(-34.1%) | -$17.45 M(-7.4%) |
Dec 2023 | -$18.84 M(+23.4%) | -$5.37 M(+18.8%) | -$18.84 M(+1.3%) |
Sept 2023 | - | -$4.52 M(+12.5%) | -$18.60 M(+6.3%) |
June 2023 | - | -$4.02 M(-18.4%) | -$17.50 M(+2.7%) |
Mar 2023 | - | -$4.93 M(-4.1%) | -$17.04 M(+11.6%) |
Dec 2022 | -$15.27 M(+5.4%) | -$5.13 M(+50.2%) | -$15.27 M(+14.1%) |
Sept 2022 | - | -$3.42 M(-4.1%) | -$13.38 M(-2.9%) |
June 2022 | - | -$3.56 M(+13.2%) | -$13.78 M(-1.8%) |
Mar 2022 | - | -$3.15 M(-3.1%) | -$14.03 M(-3.2%) |
Dec 2021 | -$14.49 M | -$3.25 M(-14.7%) | -$14.49 M(+1.8%) |
Sept 2021 | - | -$3.81 M(+0.1%) | -$14.24 M(+14.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2021 | - | -$3.81 M(+5.6%) | -$12.43 M(+12.1%) |
Mar 2021 | - | -$3.61 M(+20.3%) | -$11.10 M(+17.4%) |
Dec 2020 | -$9.45 M(+146.7%) | -$3.00 M(+49.3%) | -$9.45 M(+5.3%) |
Sept 2020 | - | -$2.01 M(-18.7%) | -$8.98 M(+17.1%) |
June 2020 | - | -$2.47 M(+25.7%) | -$7.66 M(+36.7%) |
Mar 2020 | - | -$1.97 M(-22.0%) | -$5.61 M(+46.3%) |
Dec 2019 | -$3.83 M(-47.8%) | -$2.52 M(+261.0%) | -$3.83 M(-51.6%) |
Sept 2019 | - | -$699.10 K(+68.4%) | -$7.93 M(+7.2%) |
June 2019 | - | -$415.10 K(+112.8%) | -$7.40 M(+2.3%) |
Mar 2019 | - | -$195.10 K(-97.1%) | -$7.23 M(+2.8%) |
Dec 2018 | -$7.35 M | -$6.62 M(+3794.9%) | -$7.04 M(+1571.9%) |
Sept 2018 | - | -$169.90 K(-32.3%) | -$421.00 K(+67.7%) |
June 2018 | - | -$251.10 K | -$251.10 K |
FAQ
- What is CNS Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual EBIT year-on-year change?
- What is CNS Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly EBIT year-on-year change?
- What is CNS Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals TTM EBIT year-on-year change?
What is CNS Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of CNSP is -$18.84 M
What is the all time high annual EBIT for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual earnings before interest & taxes is -$3.83 M
What is CNS Pharmaceuticals annual EBIT year-on-year change?
Over the past year, CNSP annual earnings before interest & taxes has changed by -$3.57 M (-23.39%)
What is CNS Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of CNSP is -$5.60 M
What is the all time high quarterly EBIT for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$169.90 K
What is CNS Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, CNSP quarterly earnings before interest & taxes has changed by -$1.08 M (-23.95%)
What is CNS Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of CNSP is -$17.04 M
What is the all time high TTM EBIT for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high TTM earnings before interest & taxes is -$251.10 K
What is CNS Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, CNSP TTM earnings before interest & taxes has changed by +$1.56 M (+8.38%)